** Shares of contract research firm ICON ICLR.O fall 5.8% to $169.5 premarket
** CEO Dr. Steve Cutler is retiring; COO Barry Balfe to replace him on October 1 and join the board, company says
** Dr. Cutler will continue to serve on the board as a non-executive director
** In August, a next-generation COVID-19 vaccine study, ICON was running, had been paused by U.S. funding agency BARDA after it issued a stop-work notice to the study sponsor
** As of last close, ICON stock down 14.2% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.